ArticleBMC medicine2024

Synthesizing regulatory guidance for demonstrating preclinical efficacy and translating promising cell therapies to early phase clinical trials: a scoping review.

Matthew S Jeffers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.